NASDAQ: AGIO       Agios Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
21.70   -0.63 (2.82%)  21.54 - 22.06  76,067


Avg Volume (4 weeks):736,648
4 Weeks Range:20.20 - 26.86
4 Weeks Price Volatility (%):
52 Weeks Range:20.20 - 62.155
52 Weeks Price Volatility (%):
Average Price Target: 132.00
Price Target Upside/Downside: +110.30


No recent Headlines for this stock.

Business Background

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2023  2203  366  7699 

Top 10 Active Counters
 ISBC 13.87-0.35 
 NU 3.86-0.22 
 AMD 102.742+0.271 
 NIO 16.669+0.039 
 DISCA 24.43+1.36 
 TGT 161.825-53.455 
 AMC 13.694+0.794 
 AAPL 145.70-3.54 
 SOFI 7.435+0.385 
 NVDA 179.52-2.25